secwatch.observer — SEC 8-K summary
======================================

Issuer:     IQVIA HOLDINGS INC. (IQV)
CIK:        0001478242
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001193125-25-267053
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nobel laureate Dr. William G. Kaelin Jr. appointed to IQVIA board
-----------------------------------------------------------------

- Appointment effective November 5, 2025.
- Kaelin awarded 2019 Nobel Prize in Physiology or Medicine for oxygen-sensing and VHL tumor suppressor work.
- Senior physician-scientist at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School.
- Also serves on Eli Lilly board and chairs its Science and Technology Committee.
- Board determined Kaelin meets NYSE independence standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1478242/000119312525267053/0001193125-25-267053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1478242/000119312525267053/d89736d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-267053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer